Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The v-myc oncogene.

C M Lee1, E P Reddy

  • 1Fels Institute for Cancer Research and Molecular Biology, School of Medicine, Temple University, Philadelphia, Pennsylvania 19140, USA.

Oncogene
|June 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Large-scale analysis of expressed genes from the leaf of oilseed rape (Brassica napus L.).

Plant cell reports·2019
Same author

Anticarcinogenic effect of indole-3-carbinol (I3C) on human hepatocellular carcinoma SNU449 cells.

Human & experimental toxicology·2018
Same author

Phase I/II clinical trial to assess safety and efficacy of intratumoral and subcutaneous injection of HVJ-E in castration-resistant prostate cancer patients.

Cancer gene therapy·2017
Same author

Effects of ABCB1 Genetic Polymorphism on the Oral Absorption of Losartan.

Clinical therapeutics·2016
Same author

Effects of Genetic Polymorphism of Cyp2c19 on the Pharmacokinetics of Zolpidem.

Clinical therapeutics·2016
Same author

Frequency and risk factors of drug-induced liver injury during treatment of multidrug-resistant tuberculosis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2016
Same journal

Aberrant splicing in human cancer shows possible functional impact on transcription factors.

Oncogene·2026
Same journal

The crosstalk between RNA m6A modification and protein lactylation: emerging insights into tumor progression.

Oncogene·2026
Same journal

Correction: Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.

Oncogene·2026
Same journal

Amphiregulin-mediated EGFR activation drives both intrinsic and acquired resistance to KRAS G12C inhibitors in KRAS G12C-mutant non-small cell lung cancer.

Oncogene·2026
Same journal

Histone lactylation-driven IGF2BP3 promotes intrahepatic cholangiocarcinoma progression via SPP1/CD44-dependent macrophage polarization.

Oncogene·2026
Same journal

Correction: SIRT7 activates p53 by enhancing PCAF-mediated MDM2 degradation to arrest the cell cycle.

Oncogene·2026
See all related articles

The viral oncogene v-myc drives cell transformation and proliferation. Its mutations enhance potency, impacting cell differentiation and apoptosis, with implications for tumor progression.

Area of Science:

  • Molecular Biology
  • Oncology
  • Virology

Background:

  • v-myc, the viral homolog of c-myc, is often encoded as a Gag-Myc fusion protein by acute transforming retroviruses.
  • The v-myc oncogene possesses the ability to transform various mammalian and avian cell lineages, either independently or in conjunction with other oncogenes.

Purpose of the Study:

  • To review recent developments concerning the effects of v-myc on cell growth, transformation, differentiation, and apoptosis.
  • To elucidate the critical domains of the Myc sequence essential for transformation.
  • To explore the role of secondary events, such as CSF-1 expression, in v-myc-mediated immortalization and tumor progression.

Main Methods:

  • Analysis of v-myc gene structure, including point mutations and their impact on oncogenic potential.

Related Experiment Videos

  • Investigation of the essential N- and C-termini of the Myc sequence for cellular transformation.
  • Examination of secondary events in v-myc-transformed cells, focusing on colony stimulating factor-1 (CSF-1) expression and its autocrine loop.

    • Main Results:

    • Point mutations in v-myc genes enhance its potency in transformation, proliferation, and apoptosis.
    • The N- and C-termini of the Myc sequence are essential for transformation, while the Gag portion and nuclear localization signal are dispensable.
    • In v-myc-transformed myelomonocytic cells, secondary events like CSF-1 expression are critical for immortalization and tumor progression; inhibiting this autocrine loop induces apoptosis.

    Conclusions:

    • v-myc plays a significant role in oncogenesis through its potent transformation capabilities and modulation of cellular processes.
    • While v-myc overexpression inhibits hematopoietic cell differentiation, it does not universally block differentiation in all cell types, such as neural and skeletal muscle cells.
    • Understanding the mechanisms of v-myc action, including its interaction with signaling pathways like CSF-1, is crucial for developing targeted cancer therapies.